CJ Cheiljedang Corporation Archives - Asian Scientist Magazine

cj cheiljedang corporation

VaxInnate Licenses Recombinant Flu Vaccines To South Korea’s CJ CheilJedang Corp

VaxInnate Corporation has granted CJ CheilJedang Corporation an exclusive license to manufacture, develop, and commercialize its recombinant seasonal and pandemic flu vaccines in South Korea.

Technology

Malaysia Receives US$660 Million Biotech Investment From S Korea & France

Malaysia will enter into a US$660 million joint venture partnership in industrial biotechnology with South Korea’s CJ Cheiljedang Corporation (CJ) and France’s Arkema SA (ARKEMA).

EDITOR’S PICK

The Oceans Are Running A Fever

Increasing marine heatwaves are breaking the resilience of aquatic life with long-term consequences for coastal communities.
Accelerating Advancements In Healthcare

From disease diagnostics to drug development, healthcare applications are poised to receive a major boost from the combined power of AI and supercomputing.
Bullying Could Lead To Psychosis In Teens

The study shows that bullying could alter the levels of neurotransmitter, Glutamate, which is linked with psychosis.

VaxInnate Licenses Recombinant Flu Vaccines To South Korea’s CJ CheilJedang Corp

Malaysia Receives US$660 Million Biotech Investment From S Korea & France

EDITOR’S PICK

The Oceans Are Running A Fever

Accelerating Advancements In Healthcare

Bullying Could Lead To Psychosis In Teens